Budgetary pressures are forcing reimbursement cuts and driving margin compression in already mature markets, limiting domestic growth opportunities. Meanwhile, increasing sophistication and scale of emerging market companies are helping to lower perceived mergers and acquisitions (M&A) risk. We engage with clients by providing fundraising support, divestiture services, evaluating buy and sell side strategy, and assisting with pre-deal clinical, financial, operational, tax due diligence, valuation, and post-deal integration and value creation. However, both local and in-bound HealthTech startups have been facing challenges in setting up and scaling up successfully in Singapore, the region and internationally, despite the nation having been deemed a thriving centre.
To achieve a vibrant and successful HealthTech industry locally, regionally and globally, an independent party to support a startup's journey from conceptualisation to–successful and sustainable–commercialisation is needed. If you are looking to play a role in the innovation space, we provide a comprehensive suite of services throughout the journey regardless of your and/or a HealthTech startup's maturity.
One Deals is a comprehensive approach to deal-making that emphasises integrated advice and support throughout the entire deal lifecycle. It offers a holistic approach to deal-making, providing our clients with the tools and expertise necessary to navigate the complexities of transactions and realise their strategic objectives.
We utilise One Deals based on the different objectives that our clients aim to achieve:
Deals Partner Deals Strategy & Operations, and Healthcare Leader, PwC Malaysia
Tel: +60 (3) 2173 0551